Cargando…

VT68.2: An Antibody to Chondroitin Sulfate Proteoglycan 4 (CSPG4) Displays Reactivity against a Tumor-Associated Carbohydrate Antigen

The anti-CSPG4 monoclonal antibodies (mAbs) have shown anti-tumor activity and therapeutic potential for treating breast cancer. In addition, CSPG4 is a dominant tumor-associated antigen that is also involved in normal-tissue development in humans. Therefore, the potential for off-tumor activity rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nounamo, Bernice, Jousheghany, Fariba, Siegel, Eric Robb, Post, Steven R., Kelly, Thomas, Ferrone, Soldano, Kieber-Emmons, Thomas, Monzavi-Karbassi, Behjatolah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917008/ https://www.ncbi.nlm.nih.gov/pubmed/36768830 http://dx.doi.org/10.3390/ijms24032506

Ejemplares similares

Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells
por: Cooney, Craig A, et al.
Publicado: (2011)

Chondroitin Sulfate Proteoglycan-4 (CSPG4)-Specific Monoclonal Antibody 225.28 in Detection of Acute Myeloid Leukemia Blasts
por: Fenton, Moon, et al.
Publicado: (2015)

Carbohydrate Mimetic Peptides Augment Carbohydrate-Reactive Immune Responses in the Absence of Immune Pathology
por: Hennings, Leah, et al.
Publicado: (2011)

Tumor-Associated Glycans and Immune Surveillance
por: Monzavi-Karbassi, Behjatolah, et al.
Publicado: (2013)

The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas
por: Schiffer, Davide, et al.
Publicado: (2018)

Expression analysis of carbohydrate antigens in ductal carcinoma in situ of the breast by lectin histochemistry
por: Korourian, Soheila, et al.
Publicado: (2008)

Feeding Obese Zucker Rats With Soy Protein Concentrate With High Isoflavones Compared to Low Isoflavones Leads to a Significant Reduction of Serum Tumor Necrosis Factor-α
por: Li, Wei, et al.
Publicado: (2022)

Carbohydrate-Mimetic Peptides for Pan Anti-Tumor Responses
por: Kieber-Emmons, Thomas, et al.
Publicado: (2014)

The response of phyllodes tumor of the breast to anticancer therapy: An in vitro and ex vivo study
por: Urbaniak, Alicja, et al.
Publicado: (2019)

Breast cancer survival disparity between African American and Caucasian women in Arkansas: A race-by-grade analysis
por: Monzavi-Karbassi, Behjatolah, et al.
Publicado: (2016)

Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors
por: Keleg, Shereen, et al.
Publicado: (2014)

Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas
por: Mellai, Marta, et al.
Publicado: (2020)

Expression of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma cells is downregulated upon inhibition of BRAF
por: Uranowska, Karolina, et al.
Publicado: (2021)

Pre-diagnosis blood glucose and prognosis in women with breast cancer
por: Monzavi-Karbassi, Behjatolah, et al.
Publicado: (2016)

Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects
por: Hutchins, Laura F., et al.
Publicado: (2017)

Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells
por: YAO-BORENGASSER, AIWEI, et al.
Publicado: (2015)

P10s-PADRE vaccine combined with neoadjuvant chemotherapy in ER-positive breast cancer patients induces humoral and cellular immune responses
por: Makhoul, Issam, et al.
Publicado: (2021)

Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage
por: Hsu, Shu-Hsuan Claire, et al.
Publicado: (2018)

Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy
por: Nota, Sjoerd P. F. T., et al.
Publicado: (2022)

CHST11 gene expression and DNA methylation in breast cancer
por: HERMAN, DAMIR, et al.
Publicado: (2015)

Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study
por: Hernandez Puente, Cinthia Violeta, et al.
Publicado: (2020)

Theranostic Impact of NG2/CSPG4 Proteoglycan in Cancer
por: Nicolosi, Pier Andrea, et al.
Publicado: (2015)

Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans
por: Pashov, Anastas, et al.
Publicado: (2010)

GM-CSF reduces expression of chondroitin sulfate proteoglycan (CSPG) core proteins in TGF-β-treated primary astrocytes
por: Choi, Jung-Kyoung, et al.
Publicado: (2014)

A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma
por: Hoffmann, Ricarda M., et al.
Publicado: (2020)

Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms
por: Yang, Jianbo, et al.
Publicado: (2004)

The promise of the anti-idiotype concept
por: Kieber-Emmons, Thomas, et al.
Publicado: (2012)

(212)Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
por: Kasten, Benjamin B., et al.
Publicado: (2018)

Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma
por: Riccardo, Federica, et al.
Publicado: (2019)

The Association between Genes Polymorphisms of Heparan Sulfate Proteoglycan 2 (HSPG2) and Chondroitin Sulfate Proteoglycan 2 (CSPG2) and Intracranial Aneurysm Susceptibility: A Meta-Analysis
por: LIU, Huahui, et al.
Publicado: (2019)

Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
por: Beard, Rachel E, et al.
Publicado: (2014)

Targeting the NG2/CSPG4 Proteoglycan Retards Tumour Growth and Angiogenesis in Preclinical Models of GBM and Melanoma
por: Wang, Jian, et al.
Publicado: (2011)

Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma
por: Chen, Kathryn, et al.
Publicado: (2022)

Immunohistochemical detection of the chondroitin sulfate proteoglycan 4 protein in primary and metastatic melanoma
por: Grossauer, Anna, et al.
Publicado: (2023)

Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial
por: Riccardo, Federica, et al.
Publicado: (2022)

Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B
por: Yuan, Pengfei, et al.
Publicado: (2015)

Chondroitin sulfate proteoglycan 4 specific chimeric antigen receptor therapy for pediatric solid tumors
por: Tschernia, Nicholas, et al.
Publicado: (2014)

Chondroitin Sulfate Proteoglycans in the Nervous System: Inhibitors to Repair
por: Siebert, Justin R., et al.
Publicado: (2014)

Inhibition and enhancement of neural regeneration by chondroitin sulfate proteoglycans
por: Rauvala, Heikki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_53itddt89tqmp3c2hd23fouh4g